Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TPIV 200 |
Trade Name | |
Synonyms | TPIV200|TPIV-200 |
Drug Descriptions |
TPIV 200 is a peptide vaccine that targets the folate receptor 1 (FOLR1) to activate cytotoxic T-lymphocytes against tumor cells overexpressing FOLR1 (PMID: 27294608). |
DrugClasses | FOLR1-targeted Therapy 24 |
CAS Registry Number | NA |
NCIT ID | C128898 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Durvalumab + TPIV 200 | Durvalumab TPIV 200 | 0 | 1 |
TPIV 200 | TPIV 200 | 0 | 0 |